Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Sale
Global Scleroderma Therapeutics Market: By Drug Class: Phosphodiesterase 5 Inhibitors - PHA , Endothelin Receptor Antagonists, Prostacyclin Analogues, Calcium Channel Blockers, Analgesics, Others; By Indication; Regional Analysis; Historical Market and Forecast (2016-2026); Competitive Landscape; Industry Events and Developments
Global Scleroderma Therapeutics Market Outlook
The global scleroderma therapeutics market attained a value of USD 1.7 billion in 2020. The scleroderma therapeutics market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 6.2% to reach USD 2.4 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Properties and Applications
Scleroderma refers to an autoimmune condition that affects the skin, vessels of the blood, muscles, and internal organs. Usually, the disease is caused by an abnormal immune response. Immunosuppressive medicines and, in some cases, glucocorticoids are included to treat this condition.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The drug class available in the industry can be divided into:
- Immunosuppressors
- Phosphodiesterase 5 Inhibitors - PHA
- Endothelin Receptor Antagonists
- Prostacyclin Analogues
- Calcium Channel Blockers
- Analgesics
- Others
Based on indication, the scleroderma therapeutics market can be divided into:
- Systemic
- Localized
The EMR report looks into the regional markets of scleroderma therapeutics like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The demand in the industry is mainly being driven by the use of off-label medications approved. The lack of curative drugs and a higher prevalence of off-label drug use are the underlying factors that drive interest in markets for rare diseases. The advancement of targeted biologics, as well as small molecular combination therapies, are expected to be supported in the industry. The market is also projected to be supported by the rising prevalence of scleroderma and the increasing incidences of genetic mutations combined with dramatic changes in the environment. The rising disposable incomes, allowing greater expenditure, and the existence of a well-defined regulatory framework that promotes successful therapy production in developed regions are driving the growth of the industry.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global scleroderma therapeutics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- F. Hoffman La Roche Ltd.
- Boehringer Ingelheim International GmbH
- Bristol-Myers Squibb Company [NYSE: BMY]
- arGentis Pharmaceuticals, Llc
- Prometic Life Sciences Inc.
- Akashi Therapeutics
- Kadmon Holdings, Inc.
- Emerald Health Pharmaceuticals.
- Others
The EMR report gives an in-depth insight into the scleroderma therapeutics market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Questions Answered in the Market Report:
- How has the global scleroderma therapeutics market performed in the previous years (2016-2020)?
- What is the forecast assessment of the scleroderma therapeutics market for 2021-2026?
- What are the major drivers of the historical (2016-2020) and forecast (2021-2026) periods?
- What are the major constraints of the historical (2016-2020) and forecast (2021-2026) periods?
- What are the major price indicators of the global scleroderma therapeutics market?
- What are the major demand indicators of the global scleroderma therapeutics market?
- Who are the key manufacturers in the global scleroderma therapeutics market?
- What is the degree of competition in the global scleroderma therapeutics market?
- What are the major events and developments taking place within the global industry?
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
1.1 Objectives of the Study
1.2 Key findings of the Study
2 Research Methodology
2.1 Data Extraction
2.2 Data Corroboration
2.3 Market Structure
2.4 Inference Data
3 Executive Summary
3.1 Market Overview
3.2 Market Analysis
4 Global Scleroderma Therapeutics Market Analysis
4.1 Global Scleroderma Therapeutics Historical Market (2016-2020) & Forecast (2021-2026)
4.2 Global Scleroderma Therapeutics Market Breakup by Drug Class
4.2.1 Immunosuppressors
4.2.2 Phosphodiesterase 5 Inhibitors - PHA
4.2.3 Endothelin Receptor Antagonists
4.2.4 Prostacyclin Analogues
4.2.5 Calcium Channel Blockers
4.2.6 Analgesics
4.2.7 Others
4.3 Global Scleroderma Therapeutics Market Breakup by Drug Class: Historical Market (2016-2020) & Forecast (2021-2026)
4.3.1 Immunosuppressors
4.3.2 Phosphodiesterase 5 Inhibitors - PHA
4.3.3 Endothelin Receptor Antagonists
4.3.4 Prostacyclin Analogues
4.3.5 Calcium Channel Blockers
4.3.6 Analgesics
4.3.7 Others
4.4 Global Scleroderma Therapeutics Market Breakup by Indication
4.4.1 Systemic
4.4.2 Localized
4.5 Global Scleroderma Therapeutics Market Breakup by Indication: Historical Market (2016-2020) & Forecast (2021-2026)
4.5.1 Systemic
4.5.2 Localized
4.6 Global Scleroderma Therapeutics Market Breakup by Region
4.6.1 North America
4.6.1.1 United States of America
4.6.1.2 Canada
4.6.2 Europe
4.6.2.1 Germany
4.6.2.2 United Kingdom
4.6.2.3 France
4.6.2.4 Italy
4.6.2.5 Others
4.6.3 Asia Pacific
4.6.3.1 China
4.6.3.2 Japan
4.6.3.3 India
4.6.3.4 ASEAN
4.6.3.5 Others
4.6.4 Latin America
4.6.4.1 Brazil
4.6.4.2 Argentina
4.6.4.3 Mexico
4.6.4.4 Others
4.6.5 Middle East & Africa
4.6.5.1 Saudi Arabia
4.6.5.2 United Arab Emirates
4.6.5.3 Nigeria
4.6.5.4 South Africa
4.6.5.5 Others
4.7 Global Scleroderma Therapeutics Market Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
4.7.1 North America
4.7.1.1 United States of America
4.7.1.2 Canada
4.7.2 Europe
4.7.2.1 Germany
4.7.2.2 United Kingdom
4.7.2.3 France
4.7.2.4 Italy
4.7.2.5 Others
4.7.3 Asia Pacific
4.7.3.1 China
4.7.3.2 Japan
4.7.3.3 India
4.7.3.4 ASEAN
4.7.3.5 Others
4.7.4 Latin America
4.7.4.1 Brazil
4.7.4.2 Argentina
4.7.4.3 Mexico
4.7.4.4 Others
4.7.5 Middle East & Africa
4.7.5.1 Saudi Arabia
4.7.5.2 United Arab Emirates
4.7.5.3 Nigeria
4.7.5.4 South Africa
4.7.5.5 Others
5 SWOT Analysis
5.1 Overview
5.2 Strengths
5.3 Weaknesses
5.4 Opportunities
5.5 Threats
6 Porter’s Five Forces Analysis
6.1 Overview
6.2 Buyer’s Power
6.3 Supplier’s Power
6.4 New Entrants
6.5 Degree of Rivalry
6.6 Substitutes
7 Value Chain Analysis
8 EMR’s Key Indicators for Demand
9 EMR’s Key Indicators for Price
10 Competitive Landscape & Supplier Analysis
10.1 F. Hoffman La Roche Ltd.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.2 Boehringer Ingelheim International GmbH
10.2.1 Company Overview
10.2.2 Financial Analysis
10.3 Bristol-Myers Squibb Company [BMY (NYSE)]
10.3.1 Company Overview
10.3.2 Financial Analysis
10.4 arGentis Pharmaceuticals, Llc
10.4.1 Company Overview
10.4.2 Financial Analysis
10.5 Prometic Life Sciences Inc. [LMNL (TSE)]
10.5.1 Company Overview
10.5.2 Financial Analysis
10.6 Akashi Therapeutics
10.6.1 Company Overview
10.6.2 Financial Analysis
10.7 Kadmon Holdings, Inc.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.8 Emerald Health Pharmaceuticals.
10.8.1 Company Overview
10.8.2 Financial Analysis
10.9 Others
11 Industry Events and Developments
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 1999
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$3199$2499-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$4199$3499-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$5199$4499-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar ReportsThe global oxygen therapy market attained a value of about USD 11 billion in 2020, driven by the rising prevalence of respiratory chronic diseases. Aided by the growing research and development (R&D) ...
The global topical pain relief market attained a value of nearly USD 9.13 billion in 2020, driven by the rising prevalence of arthritis and other bone-related diseases. Aided by the increasing geriatr...
The global aortic valve replacement market is expected to grow at a CAGR of 10.6% in the forecast period of 2021-2026 as per a new report by Expert Market Research.
The global radiation oncology market attained a value of nearly USD 6.7 billion in 2020, driven by the rising prevalence of cancer across the globe. Aided by the growing technological advancements, th...
Neuromodulation is defined as the alteration of nerve activity by targeting the stimulus, which could be electrical or chemical to specific neurological sites in the body. The main function of neuromo...
NEWSLETTER